Back to the Colorectal Cancer Consensus Molecular Subtype Future.

Related Articles

Back to the Colorectal Cancer Consensus Molecular Subtype Future.

Curr Gastroenterol Rep. 2019 Jan 30;21(2):5

Authors: Menter DG, Davis JS, Broom BM, Overman MJ, Morris J, Kopetz S

Abstract
PURPOSE OF REVIEW: This review seeks to provide an informed prospective on the advances in molecular profiling and analysis of colorectal cancer (CRC). The goal is to provide a historical context and current summary on how advances in gene and protein sequencing technology along with computer capabilities led to our current bioinformatic advances in the field.
RECENT FINDINGS: An explosion of knowledge has occurred regarding genetic, epigenetic, and biochemical alterations associated with the evolution of colorectal cancer. This has led to the realization that CRC is a heterogeneous disease with molecular alterations often dictating natural history, response to treatment, and outcome. The consensus molecular subtypes (CMS) classification classifies CRC into four molecular subtypes with distinct biological characteristics, which may form the basis for clinical stratification and subtype-based targeted intervention. This review summarizes new developments of a field moving "Back to the Future." CRC molecular subtyping will better identify key subtype specific therapeutic targets and responses to therapy.

PMID: 30701321 [PubMed - in process]

from A via a.sfakia on Inoreader http://bit.ly/2HLdvCW